Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Completed · Phase 4

Conditions studied: Gastroesophageal Reflux Disease

In brief

This study will be conducted in order to determine safety and efficacy esomeprazole, lansoprazole and pantoprazole control stomach acid by measuring the stomach acid in men and women of Hispanic origin who have GERD.

Key facts

Study ID

NCT00410592

Run by

AstraZeneca

People needed

90

Starts

2006-10-01

Expected to finish

2007-05-01

Last updated by the study team

2009-03-11

Who can join

Age: 18 and older, up to 69. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent
• Males and females ages 18-69 who are of Hispanic origin
• Symptoms of GERD, defined as heartburn at least 2 times a week on average over the last 3 months

You may not qualify if…

• Female patients who are pregnant or breastfeeding
• Known intolerance or lack of response to Proton Pump Inhibitors (PPIs) such as Nexium, Prevacid, or Protonix
• Current or relevant history of non-healed ulcers, stomach surgery, or esophageal surgery

Where it is running

• Research Site — Anaheim, California, United States
• Research Site — Orange, California, United States
• Research Site — San Diego, California, United States
• Research Site — Miami, Florida, United States
• Research Site — Chicago, Illinois, United States
• Research SIte — Chapel Hill, North Carolina, United States
• Research Site — Houston, Texas, United States
• Research Site — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.